- Home
- REI vs CVRX Comparison
REI vs CVRX Comparison
Compare REI & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REI | CVRX |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.3M | 201.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | REI | CVRX |
|---|---|---|
| Price | $0.99 | $6.64 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $13.17 |
| AVG Volume (30 Days) | ★ 1.5M | 282.4K |
| Earning Date | 03-04-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $308,790,652.00 | $55,969,000.00 |
| Revenue This Year | N/A | $11.91 |
| Revenue Next Year | $2.43 | $15.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.44 |
| 52 Week Low | $0.72 | $4.30 |
| 52 Week High | $1.51 | $18.55 |
Technical Indicators
Market Signals| Indicator | REI | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 64.94 | 43.42 |
| Support Level | $0.93 | $5.11 |
| Resistance Level | $1.01 | $6.09 |
| Average True Range (ATR) | 0.05 | 0.73 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 87.79 | 42.09 |
Price Performance
Historical ComparisonAbout REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.